Ally Bridge Group (NY) LLC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ally Bridge Group (NY) LLC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2022$286,618
-83.6%
159,232
-80.7%
0.28%
-75.8%
Q3 2022$1,747,000
-39.9%
823,974
-23.7%
1.15%
-56.5%
Q2 2022$2,907,000
-38.0%
1,080,5660.0%2.65%
-23.8%
Q1 2022$4,690,000
-26.1%
1,080,566
-11.8%
3.48%
+56.7%
Q4 2021$6,346,000
-31.1%
1,225,060
-18.3%
2.22%
-18.1%
Q3 2021$9,210,000
-39.2%
1,500,0000.0%2.71%
-28.1%
Q2 2021$15,150,0001,500,0003.76%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders